欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PT/H/2394/001
药品名称
Medovir
活性成分
aciclovir 250.0 mg
剂型
Powder for solution for infusion
上市许可持有人
Medochemie Iberia, S.A.
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
Greece (GR)
Latvia (LV)
Aciclovir Medochemie 250 mg pulveris infūziju šķīduma pagatavošanai
Lithuania (LT)
ACICLOVIR MEDOCHEMIE 250 mg milteliai infuziniam tirpalui
Estonia (EE)
MEDOVIR
Bulgaria (BG)
Medovir
Cyprus (CY)
Medolone 250mg Powder for solution for infusion
Romania (RO)
Medovir 250 mg Pulbere pentru soluţie perfuzabilă
Slovakia (SK)
MEDOVIR 250 mg prášok na infúzny roztok
Malta (MT)
许可日期
2020/11/05
最近更新日期
2024/06/10
药物ATC编码
J05AB01 aciclovir
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
PubAR
|
644704_20220423_PAR_MSP
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase